1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68AD5A6893B4CF01400258D4D00316BE3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/patient-focused-impact-synergizing-cross-medical-efforts-better-outcomes
18
19
20216.73.216.77
21
22
23globalbenchmarking.com
24/bestp/domrep.nsf
25BMR
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Field Medical Excellence (FME) Launch Services Excellence Patient Support Excellence Medical Operations Excellence Collections New Product Planning Medical Affairs

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Patient Advocacy

Patient-Focused Impact: Synergizing Cross-Medical Efforts to Deliver Better Patient Outcomes

Synergizing Cross-Medical Efforts to Deliver Better Patient Outcomes

Download FREE Excerpt

ID: POP-415

Features:

20 Info Graphics

51 Data Graphics

1300+ Metrics

29 Narratives

Pages: 82

Published: 2025

Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting



  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Medical Affairs sits at the center of the insight-to-impact continuum, unifying patient insights, real-world evidence, field intelligence, and cross-functional expertise to drive measurable improvements in diagnosis, adherence, and overall patient well-being. As companies sharpen their focus on the outcomes that matter most to patients, successful Medical Affairs organizations are able to link Medical strategies and activities to improved patient outcomes.

Best Practices, LLC developed this report to explore how leading companies embed patient voice and insights into strategy, integrate PROs and RWE into daily workflows, and adopt advanced technologies—like AI—to better understand the care space and enhance Medical effectiveness. This report also highlights the cultural and operational shifts required to move from siloed execution to truly connected Medical Affairs functions that share intelligence, align priorities, and elevate the quality of scientific exchange and engagement.

Drawing on benchmarking across large, mid-small, connected, and siloed organizations, this study provides senior Medical Affairs leaders with clear direction for strengthening outcomes-driven strategy, advancing evidence-based decision-making, and demonstrating Medical’s measurable contribution to improved real-world patient outcomes.

Video Brief:


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; ADVANZ PHARMA; Alnylam Pharmaceuticals; argenx; Arrowhead Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; Cytokinetics; Eva Pharma; Ferring Pharmaceuticals; Grünenthal; Insmed; Jazz Pharmaceuticals; Merck; Otsuka; Sanofi; Vertex Pharmaceuticals; Xenon Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 27 Medical Affairs leaders from 21 biopharma companies, supplemented by deep-dive interviews to capture practical examples and success stories.

Key topics covered in this report include:

  • Linking Medical Strategy to Patient Outcomes
  • High-Impact Tactics for Improving Care
  • Integration of RWE and PROs into Medical Workflows
  • AI and Technology Adoption for Patient-Centric Engagement
  • Operational and Strategic Synergies Across Medical Teams
  • Metrics and Frameworks for Measuring Patient Impact

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.
  • High-impact tactics: Connected organizations drive better outcomes by 1) wielding RWE across customer touchpoints (including Field), 2) using personalized omnichannel engagement approaches to shift care behaviors, 3) incorporating patient-friendly trial design (and MSL-driven enrollment), and 4) addressing health disparities within sub-populations.

  • Strategy synergies: Approximately 50% of companies claim overall Medical strategies are “highly connected” across the organization. Congress strategy appears best aligned, while just 26% claim Field or Publications strategies are well-connected. Just 7% report Digital strategy is well-connected. (Large pharma stands out for the high degree to which it’s Clinical/Evidence strategy is connected across teams and functions.)

Table of Contents

Sr. No.
Topic
Slide No.
I. Executive SummaryPg. 6
II. Medical Strategy and Patient FocusPg. 17
III. Medical Approaches to Drive Better Patient OutcomesPg. 25
IV. Patient-Focused Impact: Connecting Activities to Better OutcomesPg. 37
V. Building Synergies Across Technology, Insights & TalentPg. 49
VI. Appendix A: Connected Orgs Vs. Siloed Orgs (Data Segmentation)Pg. 60
VII. Appendix B: Large Pharma Vs. Mid-Small Pharma (Data Segmentation)Pg. 70
VIII. Participant DemographicsPg. 79
IX. About Best Practices, LLCPg. 82

    List of Charts & Exhibits

    I. Executive Summary

    • One-page executive summary
    • Benchmark study partners
    • Main data segments reported in this study
    • Executive takeaways from the study
    • Key insights from interviews with Medical Affairs executives
    • The growing need to prioritize patient outcomes
    • Success stories around improving health outcomes
    • Top-rated metrics for linking Medical tactics to better outcomes
    • Notable steps taken toward improved synergy in Medical Affairs
    • Top future opportunities for “Connected” Medical Affairs to improve support

    II. Medical Strategy and Patient Focus

    • Role of improved outcomes in Medical strategy
    • Outcomes-driven medical strategy
    • Role of improved outcomes in Medical strategy – Connected vs. siloed organizations
    • Driving impact with an outcomes-driven approach
    • Voices from the field around identifying care gaps and driving strategy
    • Voices from the field around integration of RWE into Medical workflows
    • Driving impact with an outcomes-driven approach – Connected vs. siloed organizations

    III. Medical Approaches to Drive Better Patient Outcomes

    • High-impact tactics for driving better patient outcomes
    • Effective tactics for improving patient outcomes – Connected vs. siloed organizations
    • Effective field medical topics for driving scientific exchange which supports better outcomes
    • Voices from the field around driving health outcomes
    • Voices from the field around measuring field engagement tactics
    • Key field medical topics which drive better health outcomes – Connected vs. siloed organizations
    • High-impact field medical topics for driving better outcomes – Large vs. mid-small organizations
    • Top success stories around improving health outcomes
    • Innovative technologies adopted by Medical Affairs to better understand the care space and enhance patient outcomes
    • Innovative technologies adopted by Medical Affairs to enhance patient outcomes – Connected vs. siloed organizations
    • Innovative technologies adopted by Medical Affairs to improve patient outcomes – Large vs. mid-small organizations

    IV. Patient-Focused Impact: Connecting Activities to Better Outcomes

    • Top-ranked metrics for measuring the impact of Medical Affairs activities on patient outcomes
    • Top-ranked metrics for assessing patient-focused impact – Connected vs. large vs. mid-small vs. siloed organizations
    • Executive narrative around driving effective Medical tactics across stakeholders
    • Critical data sources for “actionable” tracking of patient outcomes
    • Highly effective data sources for tracking patient outcomes
    • Critical data sources for tracking patient outcomes – Connected vs. siloed organizations
    • Effective use of patient-reported outcomes (PROs) to identify new support opportunities
    • Supporting advocacy-driven registries and data collection – Connected vs. siloed organizations
    • Critical data sources for tracking patient outcomes – Large vs. mid-small organizations
    • Strategies for scaling Medical Affairs effectiveness and metrics to focus on
    • Voices from the field around scaling Medical impact

    V. Connected Medical Affairs: Building Synergies To Better Leverage Technology, Insights and Talent

    • Operational Synergies across Medical teams
    • Executive narrative around changing mindset for better performance measurement
    • Executive narrative around building trust and managing change
    • Operational Synergies across Medical teams – Connected vs. siloed organizations
    • Strategic synergies across Medical teams
    • Voices from the field around strategic synergies across Medical teams
    • Strategic synergies across Medical teams – Connected vs. siloed organizations
    • Strategic synergies across Medical teams – Large vs. mid-small organizations
    • Notable steps taken toward improved synergy in Medical Affairs
    • Top future opportunities for “connected” Medical Affairs to improve support

    VI. APPENDIX A-Data Segmentation: Connected Medical Affairs Organizations vs. Siloed Medical Affairs Organizations

    • How enhanced patient outcomes shape Medical strategy
    • Leveraging an outcomes-first mindset to strengthen impact
    • High-impact tactics that meaningfully elevate patient outcomes
    • Core field medical focus areas linked to improved outcomes
    • Cutting-edge technologies advancing outcome-oriented Medical Affairs
    • Leading indicators used to assess Medical Affairs’ contribution to patient outcomes
    • Most actionable data sources for monitoring outcome trends
    • Operational synergies across Medical teams
    • Strategic synergies across Medical teams

    VII. APPENDIX B-Data Segmentation: Large Pharma vs. Mid-Small Pharma

    • Driving impact with an outcomes-driven approach
    • Field medical topics most associated with measurable outcome improvement
    • Emerging technologies adopted by Medical Affairs to enhance patient outcomes
    • Top-ranked performance metrics that quantify Medical Affairs’ outcome influence
    • High-value data sources for tracking patient outcomes
    • Operational synergies across Medical teams
    • Strategic synergies across Medical teams

    VIII. Participant Demographics

    • Therapeutic areas represented in the study
    • Geographic coverage of benchmarked Medical Affairs roles

    RELATED RESEARCH